News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Sofinnova Venture Partners X, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/01/2023 |
SC 13D/A
| Sofinnova Venture Partners X, L.P. reports a 0% stake in CinCor Pharma, Inc. |
| 08/19/2022 |
SC 13D/A
| Sofinnova Venture Partners X, L.P. reports a 14.3% stake in CinCor Pharma, Inc. |
| 02/14/2022 |
SC 13D/A
| Sofinnova Venture Partners X, L.P. reports a 5.2% stake in Y-mAbs Therapeutics, Inc. |
| 01/21/2022 |
SC 13D
| Sofinnova Venture Partners X, L.P. reports a 15.3% stake in CinCor Pharma, Inc. |
| 07/13/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 05/24/2021 |
SC 13D
| Sofinnova Venture Partners X, L.P. reports a 14.5% stake in Vera Therapeutics, Inc. |
| 03/04/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/16/2021 |
SC 13D
| Sofinnova Venture Partners X, L.P. reports a 8% stake in Bolt Biotherapeutics, Inc. |
| 07/03/2019 |
SC 13D
| Sofinnova Venture Partners X, L.P. reports a 7.4% stake in Karuna Therapeutics, Inc. |
| 10/02/2018 |
SC 13D
| Sofinnova Venture Partners X, L.P. reports a 6.3% stake in Y-mAbs Therapeutics, Inc. |
| 08/23/2016 |
D
| Form D - Notice of Exempt Offering of Securities |
|
|